Uzma Saad, Sana Anwar, Usman Zafar Khara, Maham Siddiqui, Hina Saeed


Background: Intra-abdominal infections are associated with significant morbidity and mortality. The most frequent pathogens involved are the gastrointestinal flora which can cause poly-microbial infections. Microbiological diagnosis is required to determine the aetiology and antimicrobial susceptibility of the organisms involved. Prompt initiation of antimicrobials is essential for improving patient’s outcome. Knowledge of local trends of antimicrobial resistance in nosocomial isolates is essential for empiric therapy. Methods: A total of 190 clinical isolates collected from intra-abdominal infections during July 2013 to July 2014 were included in the study. Organism identification and Antimicrobial sensitivity testing using standard biochemical tests and CLSI recommended criteria was carried out. Result: Of the total 190 isolates from abdominal infection sources 52% were from fluid sources (peritoneal & ascitic fluid), 41% were from gall bladder and 6.5% were from other abdominal sources. E. coli (46.8%) was the most frequently isolated gram negative and Enterococcus (13.1%) was the most frequently isolated gram positive organism. Carbapenem (imipenem) was the most active agent against enterobacteraceae exhibiting, 94.4% and 91.3% sensitivity against E. coli and Klebsiella respectively. While vancomycin was the most active agent against gram positive organisms. Eighty-four percent of the Enterococci isolated were sensitive to vancomycin. Most isolates exhibited resistance to one or more antibiotics. Conclusion: Continuous evolution of antimicrobial resistance patterns in bacteria necessitates updating of local data on antimicrobial susceptibility profiles to ensure the safety and efficacy of pathogen specific antimicrobial therapies.

Keywords: Intra-abdominal infections (IAI), antimicrobials; resistant; sensitive

Full Text:



Menichetti F, Sganga G. Definition and classification of intra-abdominal infections. J Chemother 2009;21(Suppl 1):3–4.

Mazukim JE, Solomon JS. Intra-abdominal infections. Surg Clin North Am 2009;89(2):421–37.

García-Sánchez JE, García-García MI, García-Garrote F, Sánchez-Romero I. Microbiological diagnosis of intra-abdominal infections. Enferm Infecc Microbiol Clin 2013;31(4):230–9.

Sartelli M, Catena F, Ansaloni L, Leppaniemi A, Taviloglu K, Goor H, et al. Complicated intra-abdominal infections in Europe: preliminary data from the first three months of the CIAO Study. World J Emerg Surg 2012;7(1):15.

Felgas ME, Barefoot L, Griffth J, Ruthazar R, Syndman DR. Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/ soft tissue infections. Eur J Clin Microbiol Infect Dis 1996;15(12):913–21.

Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJC, Baron EJ, et al. Diagnosis and Management of Complicated Intra‐abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010;50(2):133–64.

Wilton P, Smith R, Coast J, Millar M. Strategies to contain the emergence of antimicrobial resistance: a systemic review of effectiveness. J Health Serv Res Policy 2002;7(2):111–7.

Kurup A, Liau K-H, Ren J, Lu M-C, Navarro NS, Farooka MW, et al. Antibiotic management of complicated intra-abdominal infections in adults: The Asian perspective. Ann Med Surg 2014;3(3):85–91.

Sartelli M, Viale P, Catena F, Ansaloni L, Moore E, Malangoni M, et al. 2013 WSES guidelines for management of intra-abdominal infections. World J Emerg Surg 2013;8(1):3.

Hawser SP, Hoban DJ, Bouchillon SK, Badal RE. Antibiotic susceptibility of intra-abdominal infection isolates from Indian hospitals during 2008. J Med Microbiol 2010;59(9):1050–4.

Oteo J, Lazaro E, de Abajo FJ, Baquero F, Campos J. Antimicrobial resistant invasive Escherichia coli, Spain. Emerg Infect Dis 2005;11(4):546–53.

Gold HS, Moellering RC Jr. Antimicrobial-drug resistance. N Engl J Med 1996;335(19):1445–53.

Rolston KV, Kontoyiannis DP, Yadegarynia D, Raad II. Nonfermentative gram-negative bacilli in cancer patients: increasing frequency of infection and antimicrobial susceptibility of clinical isolates to fluoroquinolones. Diagn Microbiol Infect Dis 2005;51(3):215–8.

Mukhopadhyay C, Bhargava A, Ayyagari A. Two Novel clinical Presentations of Burkhulderia Cepacia infection. J Clin Microbiol 2004;42(8):3904–5.

Mahenthiralingam E, Baldwin A, Dowson CG. Burkholderia cepacia complex bacteria opportunistic pathogens with important natural biology. J Appl Microbiol 2008;104(6):1539–51.

Cinical and Laboratory Standards Instituite. Performance standards for antimicrobial susceptibility testing: Twenty- Fourth Informational Supplement. M100-S24, 2014.

Appelbaum PC. The emergence of vancomycin intermediate and vancomycin-resistant Staphylococcus aureus. Clin Microbiol Infect 2006;12:16–23.

Tiwari HK, Sen MR. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India. BMC Infect Dis 2006;6:156.


  • There are currently no refbacks.

Contact Number: +92-992-382571

email: [jamc] [@] []